Previously submitted to: JMIR Medical Informatics (no longer under consideration since Oct 16, 2019)
Date Submitted: Aug 21, 2019
Open Peer Review Period: Aug 21, 2019 - Oct 16, 2019
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note “no longer under consideration” will appear above).
Peer-review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a “Peer-Review Me” button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed “version of record” (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Feasibility and Acceptability of Video narratives intervention to Promote Medication Understanding and Use Self-Efficacy: A Pilot Study on Post-Stroke Patients
A large number of the world’s post-stroke survivors suffers from moderate to severe disability. Long-term uncontrolled stroke risk factor led to unforeseen recurrent stroke and a growing number of stroke occurrence across ages in Malaysia. This situation has led to research works tapping into patient education, especially related to the self-efficacy of understanding and taking medication appropriately. Video narratives integrated with Health Belief Model (HBM) constructs have displayed potential impact as an aide to patient education efforts.
This pilot study aimed to investigate the feasibility and acceptability of study procedures based on a trial protocol of video narratives intervention among post-stroke patients. In this paper, we report the preliminary efficacy of video narratives on medication understanding and use self-efficacy (MUSE).
A parallel-group, randomized controlled study was conducted at the neurology outpatient clinic on post-stroke patients (N=54). Baseline data included patients’ socio-demographics, medical information, and all outcome measures. Post measurement of MUSE and blood parameters were done during 3 months follow-up. Feasibility of the study included recruitment and study completion rate with patients’ feedback on the burden of study procedures and outcome measures. Whereas, acceptability of study were analyzed qualitatively. Few statistical analyses were applied to ascertain preliminary results of the video narratives.
The recruitment rate was (60/157) 38%. Nevertheless, the dropout rate of (6/60) 10% was within the acceptable range. Patients were aged between 21 and 74 years. Over 85% of them had adequate health literacy and exposure to stroke education. Most patients (> 80%) were diagnosed with ischemic stroke whereby the majority were primarily hypertensive. The technicality of randomization and patient approach were carried out with minimal challenge and adequate patient satisfaction. However, the burden of outcome measures received some concerns. The video contents received good responses about its comprehension and simplicity. Moreover, an in-depth phone interview with 8 patients found the video narratives useful and inspiring. This findings also paralleled significant preliminary improvement in MUSE (P<0.05).
The queries and feedback noted from each study’s phase in the pilot study had been acknowledged, and thus, convincingly would be taken forward to the full trial. Clinical Trial: Universal Trial Number (UTN) U1111-1201-3955
Request queued. Please wait while the file is being generated. It may take some time.
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.